Vera Therapeutics, Inc.

NASDAQ:VERA

21.9 (USD) • At close September 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -76.531-51.694-43.425-46.632-33.708-28.383-25.655-20.104-20.162-30.069-32.439-24.679-14.853-17.085-16.847-7.611-3.437-4.714-42.875-4.46-3.604-2.474
Depreciation & Amortization 0.1190.0850.0550.0241.495-0.952-0.635-1.442-0.971-0.506-0.597-0.152-0.1060.0090.0320.0590.050.035-0.6420.6730.1120.108
Deferred Income Tax 000000-3.1330.0150.029000000.2470.364-2.41001.18500
Stock Based Compensation 9.4727.7446.2175.5884.8734.1243.2212.9232.6822.6672.7482.4522.0251.6620.9620.9330.7130.4040.1430.1160.0110.061
Change In Working Capital 0-11.035-0.7285.8636.144-8.619-2.077-4.9140.0861.0368.536-0.465-7.1935.8694.2920.896-2.4210.7440.051-0.3470.4070.012
Accounts Receivables 0000000000000000000000
Change In Inventory 0000000000000000000000
Change In Accounts Payables 3.8951.5973.063-0.062-0.545-5.909-1.182-0.987.954-6.6654.979-0.072-0.2445.9430.42-0.7591.012-0.1980.57-0.3890.3830.003
Other Working Capital 0-11.035-3.7915.9256.689-2.71-0.895-3.934-7.8686.6653.557-0.393-0.007-0.0743.8721.655-3.4330.942-0.5190.0420.0240.009
Other Non Cash Items 12.142-1.103-1.301-1.7283.3278.1293.1350.5490.5640.580.594.4240.5510.5644.876-0.125-0.16-0.5915.9410.3860.399-0.012
Operating Cash Flow -54.798-54.406-39.182-36.885-24.782-33.83-25.144-22.973-17.772-26.292-21.162-18.42-19.033-8.981-6.438-5.484-7.665-4.121-27.382-2.447-2.675-2.305
Investing Activities:
Investments In Property Plant And Equipment -0.208-0.187-0.645-25.10924.7820-0.063000-0.006-0.038-0.006-0.018000000-0.047-0.052
Acquisitions Net 000000-0.01900000.00200000.79600000
Purchases Of Investments -94.728-92.523-294.015-72.945-81.088-254.967-53.2-28.672-108.849-34.209-10.563-40.403-58.087-39.43700000000
Sales Maturities Of Investments 126.061106.24673.277111.558.535.68171.81944.922.446.4432438.00115.999000000000
Other Investing Activites -2.5811.781024.871-0.089-0.2190.0190.016-0.0860.0120.006-0.002-0.042-0.039-500.79600.057000
Investing Cash Flow 28.54415.317-221.38338.317-22.677-219.28618.55616.228-86.44912.23413.437-2.44-42.094-39.455-500.79600.0570-0.047-0.052
Financing Activities:
Debt Repayment 00000000000000000.001-0.001-0.018-0.0320.574.952
Common Stock Issued 0034503.439287.5370.0870.2970.432115-0.0010.0010.00186.130.55051.176-0.0270000
Common Stock Repurchased 000-0.013000000000000000-000
Dividends Paid 0000000000000000000000
Other Financing Activities 20.2851.53300.7523.439-10.99724.8280.2970.432-7.01620.7090.9070.047-5.8624.9210-2.188-0.02779.819-0.0620.0460.015
Financing Cash Flow 20.2851.533325.9550.7393.439276.5424.8280.2970.432107.98420.7090.9080.04880.2684.921048.989-0.02879.801-0.0940.6164.967
Other Information:
Effect Of Forex Changes On Cash 000000-115.8429.371106.4710000000000000
Net Change In Cash -5.969-37.55665.392.171-44.0223.42418.24-6.448-103.78993.92612.984-19.952-61.07931.832-6.517-5.48442.12-4.14952.476-2.541-2.1062.61
Cash At End Of Period 49.12155.0992.64627.25625.08569.10545.68127.44133.889137.67843.75230.76850.72111.79979.96786.48491.96849.84853.9971.5214.0626.168